HALO logo
halo search icon
Joint Corp.

US$8.75

Price Change Indicator
0.03 (0.344%)
Joint Corp.
JYNT · NAS

Joint Corp.

Start Trading JYNT for Free

US$8.75

Price Arrow0.03 (0.344%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHammer BearishHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Joint Corp. Overview

JYNT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Neutral

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

About JYNT

icon
icon

Telephone

1.480.245.5960

icon

Address

Suite 110, 16767 North Perimeter Drive, Scottsdale, AZ 85260

Description

The Joint Corp. engages in the revolutionizing access to chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

JYNT Price Chart

Key Stats

Market Cap

US$124.31M

PE

45.40

EV/EBITDA

56.7

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7.5 - 13.47

Trade Value (12mth)

US$184,212.00

1 week

5.95%

1 month

1.63%

YTD

-1.47%

1 year

-12.89%

All time high

111.06

Key Fundamentals

EPS 3 yr Growth

343.60%

EBITDA Margin

3.50%

Operating Cashflow

$2m

Free Cash Flow Return

9.70%

ROIC

-1.40%

Interest Coverage

0.00

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

14m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

JYNT Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
02 May 26
25 April 26

JYNT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.66-0.390.19locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.66-0.390.19locklocklock
Growth
 %locklocklocklock-1,633.541.5149.4locklocklock
PE
 XlocklocklocklockN/AN/A45.4locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A56.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Joint Corp. (JYNT:NAS)?
Halo FAQ
The current share price of Joint Corp. (JYNT:NAS) is USD$8.75.
What is the 52-week high share price for Joint Corp. (JYNT:NAS)?
Halo FAQ
The 52-week high share price for Joint Corp. (JYNT:NAS) is USD$13.47.
What is the 52-week low share price for Joint Corp. (JYNT:NAS)?
Halo FAQ
The 52-week low share price for Joint Corp. (JYNT:NAS) is USD$7.50.
What is the dividend yield for Joint Corp. (JYNT:NAS)?
Halo FAQ
Joint Corp. (JYNT:NAS) does not pay a dividend.
What was Joint Corp. (JYNT:NAS) last dividend payment?
Halo FAQ
Joint Corp. (JYNT:NAS) does not pay a dividend.
What is the franking level for Joint Corp. (JYNT:NAS)?
Halo FAQ
Joint Corp. (JYNT:NAS) has a franking level of 0.00%.
In which sector is Joint Corp. (JYNT:NAS) classified?
Halo FAQ
Joint Corp. (JYNT:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Joint Corp. (JYNT:NAS)?
Halo FAQ
The current P/E ratio for Joint Corp. (JYNT:NAS) is 45.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial